Innovation & The Economy: Beyond the Headlines

A small biotech is making a bold leap, leveraging its heart disease expertise to tackle Alzheimer's and Parkinson's with a novel class of brain drugs.

As digital burnout drives a boom in restorative travel, niche media is capitalizing on silence. But can the world's quietest corners survive the spotlight?

Cape Fear BioCapital's new fund isn't just about capital. It's a strategic infusion of operator experience and partnerships set to transform NC's biotech landscape.

A $1M payout for a Kentucky motorcycle crash reveals the hidden economics of catastrophic injury, complex legal strategy, and the price of safety on our roads.

A new partnership between Mortgage Nerds and NEXA Lending reveals a strategic shift where specialized brokers scale their mission, not just their volume.

RankYak's new platform handles everything from keywords to content, aiming to replace the need for an SEO team. We dive into the tech and its market impact.

As venture-backed giants falter, Work Heights marks 12 years of profitable, independent growth. Its Brooklyn-centric model offers a new playbook.

As CEO William Brown prepares for a key investor conference, all eyes are on 3M's ability to balance its ambitious innovation goals with lingering legal battles.

In a strategic move beyond traditional benefits, iA Financial is tackling the silent economic drain of hormonal health, aiming to boost productivity and close a critical gap in Canadian healthcare.

As RNA drugs boom, a critical bottleneck emerges: quality control. A San Diego firm's new tool promises to deliver a complete picture, speeding up development.

As global laws pull teens offline, a surprising economic shift is underway. Discover how the toy industry is capitalizing on the great digital detox.

A solar EPC firm's new quality certification and licensing signal a strategic shift, promising consistent, complex project delivery on a national scale.

JATT III Acquisition Corp's $60M IPO isn't just another SPAC. It’s a calculated bet by a proven team on the future of AI in drug discovery. But does it signal a new era for biotech M&A?

Saudi Arabia's agreement for Expo 2030 is more than a legal formality; it's a strategic blueprint for its post-oil ambitions and a new model for global events.

A rural Kansas school district's adoption of AI gun detection highlights a national trend, pitting the promise of instant alerts against deep privacy concerns.

The USPS named Intralox its Supplier of the Year, but the real story is the tech behind the prize. We explore the partnership transforming parcel delivery.

A $1.8M settlement between a government contractor and the DOJ seems straightforward. But explosive allegations of retaliation and 'weaponization' by the SEC tell another story.

A niche M&A deal for a vegetation management firm reveals a hot market for essential infrastructure services fueled by technology and recurring revenue.

The strategic acquisition merges autonomous AI defense with financial risk quantification, signaling a major shift in how businesses will fight and fund security.

As a key forum convenes in Los Alamos, companies like Verdera Energy are betting big on domestic uranium. Is this the dawn of a U.S. nuclear renaissance?